Lifecare BioSciences develops infection control solutions focused on reducing CLABSI in hospital and ICU environments. Central Line Associated Bloodstream Infection remains a serious clinical concern, and our kits are designed to minimize CLABSI risk through sterile components and standardized insertion support. By promoting evidence-based catheterization practices, we help healthcare institutions strengthen infection prevention measures. Our goal is to improve patient safety and reduce complication rates in critical care settings.